DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Sotalol (Sotalol Hydrochloride) - Published Studies

 
 



Sotalol Related Published Studies

Well-designed clinical trials related to Sotalol

The efficacy of sotalol in preventing postoperative atrial fibrillation: a meta-analysis. [2011]

The Drug And Pace Health cliNical Evaluation (DAPHNE) study: a randomized trial comparing sotalol versus beta-blockers to treat symptomatic atrial fibrillation in patients with brady-tachycardia syndrome implanted with an antitachycardia pacemaker. [2008.08]

The clinical noncompliance of oral sotalol/magnesium for prophylactic treatment of atrial fibrillation after coronary artery bypass grafting. [2007.07]

Azimilide vs. placebo and sotalol for persistent atrial fibrillation: the A-COMET-II (Azimilide-CardiOversion MaintEnance Trial-II) trial. [2006.09]

Effect of amiodarone and sotalol on ventricular defibrillation threshold: the optimal pharmacological therapy in cardioverter defibrillator patients (OPTIC) trial. [2006.07.11]

An evaluation of the impact of oral magnesium lactate on the corrected QT interval of patients receiving sotalol or dofetilide to prevent atrial or ventricular tachyarrhythmia recurrence. [2006.04]

A randomized trial of prophylactic antiarrhythmic agents (amiodarone and sotalol) in patients with atrial fibrillation for whom direct current cardioversion is planned. [2006.04]

Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC Study: a randomized trial. [2006.01.11]

Randomized double-blind trial of sotalol versus lignocaine in out-of-hospital refractory cardiac arrest due to ventricular tachyarrhythmia. [2005.09]

Assessment of the effect of a single oral dose of telithromycin on sotalol-induced qt interval prolongation in healthy women. [2005.08]

Amiodarone versus sotalol for atrial fibrillation. [2005.05.05]

The effects of sotalol on ventricular repolarization during exercise. [2005.04]

Sotalol versus propafenone for long-term maintenance of normal sinus rhythm in patients with recurrent symptomatic atrial fibrillation. [2004.12.15]

Amiodarone versus sotalol for the treatment of atrial fibrillation after open heart surgery: the Reduction in Postoperative Cardiovascular Arrhythmic Events (REDUCE) trial. [2004.10]

Magnesium in addition to sotalol does not influence the incidence of postoperative atrial tachyarrhythmias after coronary artery bypass surgery. [2004.06]

Preoperative use of sotalol versus atenolol for atrial fibrillation after cardiac surgery. [2004.03]

Rapid loading of sotalol or amiodarone for management of recent onset symptomatic atrial fibrillation: a randomized, digoxin-controlled trial. [2004.01]

Comparison of sotalol versus amiodarone in maintaining stability of sinus rhythm in patients with atrial fibrillation (Sotalol-Amiodarone Fibrillation Efficacy Trial [Safe-T]). [2003.08.15]

Combination therapy for prevention of atrial fibrillation after coronary artery bypass surgery: a randomized trial of sotalol and magnesium. [2003.06]

Efficacy of metoprolol and sotalol in the prevention of recurrences of sustained ventricular tachyarrhythmias in patients with an implantable cardioverter defibrillator. [2002.11]

Combination of sotalol and magnesium prevents atrial fibrillation after coronary artery bypass grafting. [2002.09]

A randomised cross-over study on the haemodynamic effects of oral dofetilide compared with oral sotalol in patients with ischaemic heart disease and sustained ventricular tachycardia. [2002.06]

A multicentre, double-blind randomized crossover comparative study on the efficacy and safety of dofetilide vs sotalol in patients with inducible sustained ventricular tachycardia and ischaemic heart disease. [2001.12]

Effect of metoprolol and d,l-sotalol on microvolt-level T-wave alternans. Results of a prospective, double-blind, randomized study. [2001.12]

Effect of Sotalol in the prevention of atrial fibrillation following coronary artery bypass grafting. [2001.10]

Long-term efficacy and safety of propafenone and sotalol for the maintenance of sinus rhythm after conversion of recurrent symptomatic atrial fibrillation. [2001.09.15]

Maintenance of sinus rhythm after electrical cardioversion of persistent atrial fibrillation; sotalol vs bisoprolol. [2001.08]

Sotalol vs metoprolol for ventricular rate control in patients with chronic atrial fibrillation who have undergone digitalization: a single-blinded crossover study. [2001.01]

Repolarization changes in a double-blind crossover study of dofetilide versus sotalol in the treatment of ventricular tachycardia. [2000.11]

Amiodarone, sotalol, or propafenone in atrial fibrillation: which is preferred to maintain normal sinus rhythm? [2000.11]

Low dose amiodarone and sotalol in the treatment of recurrent, symptomatic atrial fibrillation: a comparative, placebo controlled study. [2000.09]

The effect of oral magnesium, alone or as an adjuvant to sotalol, after cardioversion in patients with persistent atrial fibrillation. [2000.07]

Prophylaxis of supraventricular and ventricular arrhythmias after coronary artery bypass grafting with low-dose sotalol. [2000.07]

A prospective, randomized controlled trial comparing the efficacy and safety of sotalol, amiodarone, and digoxin for the reversion of new-onset atrial fibrillation. [2000.07]

Efficacy and safety of sotalol versus quinidine for the maintenance of sinus rhythm after conversion of atrial fibrillation. SOCESP Investigators. The Cardiology Society of Sao Paulo. [1999.11.01]

Maintenance of sinus rhythm with oral d,l-sotalol therapy in patients with symptomatic atrial fibrillation and/or atrial flutter. d,l-Sotalol Atrial Fibrillation/Flutter Study Group. [1999.08.01]

Oral d,l sotalol reduces the incidence of postoperative atrial fibrillation in coronary artery bypass surgery patients: a randomized, double-blind, placebo-controlled study. [1999.08]

An open label, randomised, crossover study comparing sotalol and atenolol in the treatment of symptomatic paroxysmal atrial fibrillation. [1999.08]

Pharmacokinetic, pharmacodynamic, and safety evaluation of an accelerated dose titration regimen of sotalol in healthy middle-aged subjects. [1999.07]

Prevention of implantable-defibrillator shocks by treatment with sotalol. d,l-Sotalol Implantable Cardioverter-Defibrillator Study Group. [1999.06.17]

Comparison of sotalol with amiodarone for long-term treatment of spontaneous sustained ventricular tachyarrhythmia based on coronary artery disease. [1999.03]

Suppression of sustained ventricular tachyarrhythmias: a comparison of d,l-sotalol with no antiarrhythmic drug treatment. [1999.01]

Comparison of metoprolol and sotalol in preventing ventricular tachyarrhythmias after the implantation of a cardioverter/defibrillator. [1998.09.15]

Significance of Supraventricular Tachyarrhythmias After Coronary Artery Bypass Graft Surgery and Their Prevention by Low-Dose Sotalol: A Prospective Double-Blind Randomized Placebo-Controlled Study. [1998.07]

Adverse effects of a single dose of (+)-sotalol in patients with mild stable asthma. [1998.07]

Prospective comparison of flecainide versus sotalol for immediate cardioversion of atrial fibrillation. [1998.06.15]

Superiority of ibutilide (a new class III agent) over DL-sotalol in converting atrial flutter and atrial fibrillation. The Ibutilide/Sotalol Comparator Study Group. [1998.06]

Selective versus non-selective antiarrhythmic approach for prevention of atrial fibrillation after coronary surgery: is there a need for pre-operative risk stratification? A prospective placebo-controlled study using low-dose sotalol. [1998.05]

Absorption kinetics of oral sotalol combined with cisapride and sublingual sotalol in healthy subjects. [1998.05]

Low-dose amiodarone versus sotalol for suppression of recurrent symptomatic atrial fibrillation. [1998.04.15]

Mortality in the Survival With ORal D-sotalol (SWORD) trial: why did patients die? [1998.04.01]

[Analysis of atrial fibrillation recurrence during therapy with sotalol or quinidine. Researchers of +SOCESP] [1998.01]

Comparison of sotalol and metoprolol in the prevention of atrial fibrillation after coronary artery bypass surgery. [1998.01]

Prevention of supraventricular tachyarrhythmias after open heart operation by low-dose sotalol: a prospective, double-blind, randomized, placebo-controlled study. [1997.10]

A pharmacokinetic-pharmacodynamic model of d-sotalol Q-Tc prolongation during intravenous administration to healthy subjects. [1997.09]

The effects of antihypertensive combination therapy on lipid and glucose metabolism: hydrochlorothiazide plus sotalol vs. hydrochlorothiazide plus captopril. [1997.06]

Comparisons of oral propafenone and sotalol as an initial treatment in patients with symptomatic paroxysmal atrial fibrillation. [1997.04.01]

Multicenter comparative study of the efficacy and safety of sotalol in the prophylactic treatment of patients with paroxysmal supraventricular tachyarrhythmias. [1997.04]

Oxygen uptake kinetics and cardiopulmonary performance in lone atrial fibrillation and the effects of sotalol. [1997.04]

Interaction between sotalol and an antacid preparation. [1997.03]

Hemodynamic performances in patients treated with sotalol after electrical cardioversion of atrial fibrillation. [1997.01]

Hemodynamic effects of the class III antiarrhythmic drug, d-sotalol, in patients with congestive heart failure. [1996.12.15]

Pharmacokinetics and pharmacodynamics of (+/-)-sotalol in healthy male volunteers. [1996.11]

Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. The SWORD Investigators. Survival With Oral d-Sotalol. [1996.07.06]

A perspective on the ESVEM trial current knowledge: sotalol should not be the first-line agent in the management of ventricular arrhythmias. [1996.05]

[Propafenone and sotalol: long-term efficacy and tolerability in the prevention of paroxysmal atrial fibrillation. A placebo-controlled double-blind study] [1996.04]

Metoprolol versus sotalol in the treatment of sustained ventricular tachycardia. [1995.10]

Efficacy and proarrhythmic hazards of pharmacologic cardioversion of atrial fibrillation: prospective comparison of sotalol versus quinidine. [1995.10]

Efficacy and safety of d-sotalol, a pure class III antiarrhythmic compound, in patients with symptomatic complex ventricular ectopy. Results of a multicenter, randomized, double-blind, placebo-controlled dose-finding study. The d-Sotalol PVC Study Group. [1995.09.15]

Comparison of sotalol with digoxin-quinidine for conversion of acute atrial fibrillation to sinus rhythm (the Sotalol-Digoxin-Quinidine Trial). [1995.09.01]

[Testing of bioequivalence of a new sotalol hydrochloride preparation in comparison to a standard formulation] [1995.08]

Survival with oral d-sotalol in patients with left ventricular dysfunction after myocardial infarction: rationale, design, and methods (the SWORD trial). [1995.05.15]

Intravenous sotalol for the termination of supraventricular tachycardia and atrial fibrillation and flutter: a multicenter, randomized, double-blind, placebo-controlled study. Sotalol Multicenter Study Group. [1995.04]

Aggravation of postcardioversion atrial dysfunction by sotalol. [1995.03.01]

Multicenter trial of sotalol compared with procainamide in the suppression of inducible ventricular tachycardia: a double-blind, randomized parallel evaluation. Sotalol Multicenter Study Group. [1995.01]

[A comparison between flecainide and sotalol in the prevention of recurrences of paroxysmal atrial fibrillation] [1995.01]

Electrophysiologic effects of sotalol and amiodarone in patients with sustained monomorphic ventricular tachycardia. [1994.12.01]

Effects of amiodarone, sematilide, and sotalol on QT dispersion. [1994.11.01]

Hemodynamic effects and safety of sotalol in the prevention of supraventricular arrhythmias after coronary artery bypass surgery. [1994.08]

Double-blind trial of lignocaine versus sotalol for acute termination of spontaneous sustained ventricular tachycardia. [1994.07.02]

[Efficacy of sotalol in idiopathic ventricular arrhythmia originating in the right ventricular outflow tract] [1994.07]

[Bioequivalence of a new tablet formulation of sotalol hydrochloride in comparison to a standard preparations] [1994.05]

Comparative effects of the combination of digoxin and dl-sotalol therapy versus digoxin monotherapy for control of ventricular response in chronic atrial fibrillation. dl-Sotalol Atrial Fibrillation Study Group. [1994.03]

[Sotalol and quinidine/verapamil (Cordichin) in chronic atrial fibrillation--conversion and 12-month follow-up--a randomized comparison] [1994]

Comparative efficacy of sotalol and class I antiarrhythmic agents in patients with ventricular tachycardia or fibrillation: results of the Electrophysiology Study Versus Electrocardiographic Monitoring (ESVEM) Trial. [1993.11]

Usefulness of sotalol for life-threatening ventricular arrhythmias. [1993.08.12]

Oral flecainide, sotalol, and verapamil for the termination of paroxysmal supraventricular tachycardia. [1993.07]

d-sotalol reduces heart rate in vivo through a beta-adrenergic receptor-independent mechanism. [1993.04]

Propafenone versus sotalol for suppression of recurrent symptomatic atrial fibrillation. [1993.03.01]

Oral sotalol reduces the incidence of atrial fibrillation after coronary artery bypass surgery. [1993.02]

Randomized crossover comparison of the electrophysiologic and antiarrhythmic efficacy of oral cibenzoline and sotalol for sustained ventricular tachycardia. [1993.01]

Effect of sotalol on arrhythmias and exercise tolerance in patients with hypertrophic cardiomyopathy. [1993]

Prediction of sotalol-induced maximum steady-state QTc prolongation from single-dose administration in healthy volunteers. [1992.10]

Effectiveness of sotalol in preventing supraventricular tachyarrhythmias shortly after coronary artery bypass grafting. [1991.11.01]

Efficacy and safety of intravenous sotalol for termination of paroxysmal supraventricular tachycardia. The Sotalol Versus Placebo Multicenter Study Group. [1991.07.01]

Usefulness of d, I sotalol for suppression of chronic ventricular arrhythmias. [1991.03.01]

Reduction in QT dispersion by sotalol following myocardial infarction. [1991.03]

Rate dependence of sotalol-induced prolongation of ventricular repolarization during exercise in humans. [1991.02]

Efficacy and safety of low- and high-dose sotalol versus propranolol in the prevention of supraventricular tachyarrhythmias early after coronary artery bypass operations. [1990.12]

Sotalol versus quinidine for the maintenance of sinus rhythm after direct current conversion of atrial fibrillation. [1990.12]

A mechanism of D-(+)-sotalol effects on heart rate not related to beta-adrenoceptor antagonism. [1990.08]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017